Lv2
200 积分 2022-01-23 加入
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
20分钟前
待确认
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer
1小时前
已完结
Pembrolizumab in HER2-Positive Gastric Cancer
1小时前
已完结
Oxaliplatin, 5-Fluorouracil and Nab-paclitaxel as perioperative regimen in patients with resectable gastric adenocarcinoma: A GERCOR phase II study (FOXAGAST)
1个月前
已完结
Postoperative imatinib in patients with intermediate risk gastrointestinal stromal tumor
2个月前
已完结
CT features combined with RECIST 1.1 criteria improve progression assessments of sunitinib-treated gastrointestinal stromal tumors
2个月前
已完结
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials
3个月前
已完结
Recurrent desmoplastic small round cell tumor responding to an mTOR inhibitor containing regimen
4个月前
已完结
Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial
4个月前
已完结
Response to Alpelisib in an Adolescent With PIK3CA-Mutated Metastatic Gastrointestinal Stromal Tumor
5个月前
已完结
皖公网安备34019202002308
